- Home
- ANVS vs BHAT Comparison
ANVS vs BHAT Comparison
Compare ANVS & BHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- BHAT
- Stock Information
- Founded
- ANVS 2008
- BHAT 2010
- Country
- ANVS United States
- BHAT China
- Employees
- ANVS N/A
- BHAT N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- BHAT Recreational Games/Products/Toys
- Sector
- ANVS Health Care
- BHAT Consumer Discretionary
- Exchange
- ANVS Nasdaq
- BHAT Nasdaq
- Market Cap
- ANVS 53.3M
- BHAT 59.1M
- IPO Year
- ANVS 2020
- BHAT 2019
- Fundamental
- Price
- ANVS $3.69
- BHAT $1.28
- Analyst Decision
- ANVS Strong Buy
- BHAT
- Analyst Count
- ANVS 3
- BHAT 0
- Target Price
- ANVS $13.50
- BHAT N/A
- AVG Volume (30 Days)
- ANVS 3.0M
- BHAT 58.7K
- Earning Date
- ANVS 11-12-2025
- BHAT 12-22-2025
- Dividend Yield
- ANVS N/A
- BHAT N/A
- EPS Growth
- ANVS N/A
- BHAT N/A
- EPS
- ANVS N/A
- BHAT N/A
- Revenue
- ANVS N/A
- BHAT $18,724,190.00
- Revenue This Year
- ANVS N/A
- BHAT N/A
- Revenue Next Year
- ANVS N/A
- BHAT N/A
- P/E Ratio
- ANVS N/A
- BHAT N/A
- Revenue Growth
- ANVS N/A
- BHAT N/A
- 52 Week Low
- ANVS $1.11
- BHAT $1.25
- 52 Week High
- ANVS $7.52
- BHAT $24.50
- Technical
- Relative Strength Index (RSI)
- ANVS 77.19
- BHAT 29.28
- Support Level
- ANVS $2.11
- BHAT $1.25
- Resistance Level
- ANVS $4.00
- BHAT $1.57
- Average True Range (ATR)
- ANVS 0.35
- BHAT 0.07
- MACD
- ANVS 0.15
- BHAT -0.02
- Stochastic Oscillator
- ANVS 70.34
- BHAT 15.15
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.